3

FORM 3 SUBMISSION

Company: LIGAND PHARMACEUTICALS INC
Filed: September 30, 2022
Period of Report: September 30, 2022
Accession Number: 0000899243-22-032347

View Document ↗ View on SEC.gov ↗